Executive Vice President, Corporate Affairs and Chief Communications Officer, Allergan
Alex Kelly is Executive Vice President, Corporate Affairs and Chief Communications Officer of Allergan. He was appointed to this position on April 20, 2015. Previously, he served as Senior Vice President, Chief Integration Officer, where he co-led the integration of Allergan and Actavis and led the integration of Forest Laboratories following its acquisition by Actavis. Prior to joining Actavis, Mr. Kelly was Senior Vice President, Chief Communications Officer, Public Affairs and Investor Relations at Forest Laboratories. In that role, he led Forest’s corporate communications and investor relations programs. While at Forest, he led the integration of Aptalis Pharma following its acquisition in January 2014. Kelly also served as Vice President, Investor Relations at Bausch + Lomb. Kelly served as Senior Vice President, Investor Relations at Merck & Co., Inc. following the combination with Schering-Plough where he led the Global Communications and Investor Relations team. Kelly previously worked for Novartis as Executive Director, Investor Relations, after spending 14 years at Pharmacia. Kelly holds a Bachelor of Science in Pharmacy from Purdue University, where he graduated Cum Laude. Kelly currently serves as the chair of the Health Institute of New Jersey Board of Trustees.